About Bilcare Limited
Data last updated: 01 July 2026
Bilcare Limited is a public limited company based in Pune, Maharashtra, India. It specialises in packaging films and foils, a part of the broader packaging sector. Incorporated on 01 July 1987, the company has been in operation for over 39 years.
Registered with ROC Pune under CIN L28939PN1987PLC043953. Listed on BSE: 526853.
Capital: an authorised share capital of ₹45 Cr and a paid-up capital of ₹23.55 Cr. Formerly known as Bhandari Paper Products Private Limited. It is led by directors including Shreyans Mohan Bhandari and Rajesh Shankarrao Devene.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: Gat No 1028 At Village Shiroli Tal Khed Rajgurnagar, Pune, Maharashtra, India – 410505.
As per the financials filed for FY 2025, the company reported a revenue of ₹806.5 Cr, a growth of 5% compared to the previous year.
The company has a workforce of approximately 70 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Bilcare. As per MCA filings, the company has open charges of ₹666.96 Cr and satisfied charges of ₹3,764.67 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bilcare.com.
-
Email*****@*****.com
-
Telephone**************
-
Website
-
Social Media
-
Registered AddressGat No 1028 At Village Shiroli Tal Khed Rajgurnagar, Pune, Maharashtra, India – 410505
-
IndustryPackaging, Packaging Films & Foils, Pharmaceutical Packaging Solutions
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Bilcare Limited
Bilcare Limited has one previous CIN (Corporate Identification Number): U28939PN1987PLC043953. The current CIN is L28939PN1987PLC043953, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L28939PN1987PLC043953 | Current |
| U28939PN1987PLC043953 | Previous |
Associated Brands with Bilcare Limited
Bilcare Limited operates one associated brand: Bilcare. These brands represent Bilcare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical packaging, clinical supplies, and anti-counterfeiting solutions are provided. | bilcare.com |
Competitors & Alternatives of Bilcare Limited
Brands and companies operating in the same space as Bilcare Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
|
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
|
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
|
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
|
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
|
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
|
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
|
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Bilcare Limited
Bilcare Limited is engaged in the principal business activity of support service to organizations, with detailed activities including other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | ********* |
Auditor Details of Bilcare Limited
Bilcare Limited is audited by K R MINIYAR & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K R MINIYAR & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Bilcare Limited
Bilcare Limited is currently managed by 8 directors, with 37 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreyans Mohan Bhandari | Managing Director | 01 Jul 2022 | 4 Years 0 Months | Current |
|
Rajesh Shankarrao Devene
Also directs:
Bilcare Limited
|
Director | 22 Apr 2019 | 7 Years 2 Months | Current |
|
Alka Sagar
Also directs:
Bilcare Limited
|
Director | 14 Aug 2024 | 1 Years 10 Months | Current |
|
Kavita Sumit Bhansali
Also directs:
Bilcare Limited, Bilcare Pharma Solutions Limited
|
Whole-Time Director | 14 Aug 2023 | 2 Years 10 Months | Current |
|
Ashwini Ashok Hasabnis
Also directs:
Bilcare Limited, Populace Connect Advisors Llp
|
Additional Director | 25 Apr 2026 | 0 Years 2 Months | Current |
Financials of Bilcare Limited FY 2025 filings available
Bilcare Limited reported revenue of ₹806.5 Cr (up 5% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Bilcare Limited
As of FY 2023, Bilcare Limited's shareholding pattern shows 30.01% by promoters, 69.58% by public shareholders, 0.42% by others. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Bilcare Limited
Bilcare Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Bilcare Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Caprihans India Limited | L29150MH1946PLC004877 |
**.**%
|
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Bilcare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2023 | Others | ₹50 Cr | Open |
| 28 Mar 2023 | Others | ₹616.96 Cr | Open |
| 26 Feb 2018 | Lakshmi Vilas Bank Limited | ₹91.62 Cr | Satisfied |
| 10 Jun 2015 | Others | ₹44.92 Cr | Satisfied |
| 14 Oct 2014 | Lakshmi Vilas Bank Limited | ₹25.25 Cr | Satisfied |
Total charge records: 31 View all charges
Employees and EPFO Compliance at Bilcare Limited
Bilcare Limited has a workforce of 70 employees as of Apr 10, 2024.
Employee Count & EPFO Data of Bilcare Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Bilcare Limited
GSTIN & GST Filing Data of Bilcare Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Bilcare Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Bilcare Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Bilcare Limited
MSME Payment Delays by Bilcare Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Bilcare Limited
Subsidiaries & Group Companies of Bilcare Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Bilcare Limited with ownership details.
MCA Filings & Documents of Bilcare Limited
MCA Filings & Documents of Bilcare Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Bilcare Limited
Recent News on Bilcare Limited
Frequently Asked Questions about Bilcare Limited
Bilcare Limited is an active public limited company in the packaging sector based in Pune, Maharashtra, India. It was incorporated on 01 July 1987 (39+ years old) and is registered under CIN L28939PN1987PLC043953. Listed on BSE: 526853. The company has 70 employees.
Bilcare Limited reported revenue of ₹806.5 Cr for FY 2025 (up 5.00% YoY).
The current directors of Bilcare Limited are:
- Shreyans Mohan Bhandari
- Mohan Harakchand Bhandari
- Rajesh Shankarrao Devene
- Alka Sagar
- Sagar Ramnarayan Baheti
- Kavita Sumit Bhansali
- Deepa Mathur
- Ashwini Ashok Hasabnis
The primary industry of Bilcare Limited is packaging. The company specifically operates in packaging films and foils. The company is currently active in this sector.
Yes. Bilcare Limited is listed on BSE with code 526853.
Bilcare Limited can be reached at the registered office: Gat No 1028 At Village Shiroli Tal Khed Rajgurnagar, Pune, Maharashtra, India – 410505, or through the website bilcare.com.